ALBO Annual Current Liabilities
$45.35 M
+$20.07 M+79.36%
31 December 2021
Summary:
As of January 19, 2025, ALBO annual total current liabilities is $45.35 million, with the most recent change of +$20.07 million (+79.36%) on December 31, 2021. During the last 3 years, it has risen by +$32.52 million (+253.58%).ALBO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO Quarterly Current Liabilities
$37.82 M
-$5.77 M-13.24%
30 September 2022
Summary:
As of January 19, 2025, ALBO quarterly total current liabilities is $37.82 million, with the most recent change of -$5.77 million (-13.24%) on September 30, 2022. Over the past year, it has increased by +$4.67 million (+14.09%).ALBO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +79.4% | +14.1% |
| 3 y3 years | +253.6% | +206.8% |
| 5 y5 years | +471.9% | +376.9% |
ALBO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -16.6% |
Albireo Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $37.82 M(-13.2%) |
| June 2022 | - | $43.59 M(+38.4%) |
| Mar 2022 | - | $31.51 M(-30.5%) |
| Dec 2021 | $45.35 M(+79.4%) | $45.35 M(+36.8%) |
| Sept 2021 | - | $33.15 M(+22.8%) |
| June 2021 | - | $26.99 M(+21.5%) |
| Mar 2021 | - | $22.21 M(-12.1%) |
| Dec 2020 | $25.28 M(+33.6%) | $25.28 M(+19.1%) |
| Sept 2020 | - | $21.23 M(+23.3%) |
| June 2020 | - | $17.22 M(+13.7%) |
| Mar 2020 | - | $15.15 M(-20.0%) |
| Dec 2019 | $18.92 M(+47.6%) | $18.92 M(+53.5%) |
| Sept 2019 | - | $12.33 M(+4.6%) |
| June 2019 | - | $11.79 M(+18.5%) |
| Mar 2019 | - | $9.94 M(-22.5%) |
| Dec 2018 | $12.82 M(+61.7%) | $12.82 M(+41.2%) |
| Sept 2018 | - | $9.09 M(+14.8%) |
| June 2018 | - | $7.91 M(+10.6%) |
| Mar 2018 | - | $7.16 M(-9.7%) |
| Dec 2017 | $7.93 M(-37.6%) | $7.93 M(-0.0%) |
| Sept 2017 | - | $7.93 M(+7.5%) |
| June 2017 | - | $7.38 M(-18.7%) |
| Mar 2017 | - | $9.07 M(+338.1%) |
| Dec 2016 | $12.71 M(+513.6%) | - |
| Sept 2016 | - | $2.07 M(-25.2%) |
| Sept 2016 | $2.07 M(+14.5%) | - |
| June 2016 | - | $2.77 M(+25.3%) |
| Mar 2016 | - | $2.21 M(+55.6%) |
| Dec 2015 | - | $1.42 M(-21.5%) |
| Sept 2015 | $1.81 M(+11.9%) | $1.81 M(-28.3%) |
| June 2015 | - | $2.52 M(+19.9%) |
| Mar 2015 | - | $2.10 M(+24.4%) |
| Dec 2014 | - | $1.69 M(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | $1.62 M(-33.8%) | $1.62 M(-17.7%) |
| June 2014 | - | $1.96 M(+5.9%) |
| Mar 2014 | - | $1.85 M(-38.9%) |
| Dec 2013 | - | $3.03 M(+24.3%) |
| Sept 2013 | $2.44 M(-12.2%) | $2.44 M(-4.6%) |
| June 2013 | - | $2.56 M(+30.2%) |
| Mar 2013 | - | $1.97 M(-54.1%) |
| Dec 2012 | - | $4.28 M(+54.0%) |
| Sept 2012 | $2.78 M(-15.5%) | $2.78 M(+0.4%) |
| June 2012 | - | $2.77 M(+2.0%) |
| Mar 2012 | - | $2.71 M(-22.5%) |
| Dec 2011 | - | $3.50 M(+6.5%) |
| Sept 2011 | $3.29 M(-25.0%) | $3.29 M(+1.8%) |
| June 2011 | - | $3.23 M(+5.5%) |
| Mar 2011 | - | $3.06 M(-42.8%) |
| Dec 2010 | - | $5.35 M(+22.0%) |
| Sept 2010 | $4.39 M(-51.7%) | $4.39 M(-14.2%) |
| June 2010 | - | $5.11 M(-29.7%) |
| Mar 2010 | - | $7.27 M(+32.9%) |
| Dec 2009 | - | $5.47 M(-39.8%) |
| Sept 2009 | $9.09 M(+0.7%) | $9.09 M(-2.5%) |
| June 2009 | - | $9.32 M(+1.7%) |
| Mar 2009 | - | $9.16 M(+15.0%) |
| Dec 2008 | - | $7.96 M(-11.7%) |
| Sept 2008 | $9.02 M(+70.8%) | $9.02 M(+40.6%) |
| June 2008 | - | $6.42 M(-4.5%) |
| Mar 2008 | - | $6.72 M(-3.3%) |
| Dec 2007 | - | $6.95 M(+31.6%) |
| Sept 2007 | $5.28 M(+128.6%) | $5.28 M(+54.2%) |
| June 2007 | - | $3.43 M(-17.2%) |
| Mar 2007 | - | $4.14 M(+54.3%) |
| Dec 2006 | - | $2.68 M(+16.1%) |
| Sept 2006 | $2.31 M(+327.2%) | $2.31 M(+327.2%) |
| Sept 2005 | $541.00 K | $541.00 K |
FAQ
- What is Albireo Pharma annual total current liabilities?
- What is the all time high annual current liabilities for Albireo Pharma?
- What is Albireo Pharma annual current liabilities year-on-year change?
- What is Albireo Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Albireo Pharma?
- What is Albireo Pharma quarterly current liabilities year-on-year change?
What is Albireo Pharma annual total current liabilities?
The current annual current liabilities of ALBO is $45.35 M
What is the all time high annual current liabilities for Albireo Pharma?
Albireo Pharma all-time high annual total current liabilities is $45.35 M
What is Albireo Pharma annual current liabilities year-on-year change?
Over the past year, ALBO annual total current liabilities has changed by +$20.07 M (+79.36%)
What is Albireo Pharma quarterly total current liabilities?
The current quarterly current liabilities of ALBO is $37.82 M
What is the all time high quarterly current liabilities for Albireo Pharma?
Albireo Pharma all-time high quarterly total current liabilities is $45.35 M
What is Albireo Pharma quarterly current liabilities year-on-year change?
Over the past year, ALBO quarterly total current liabilities has changed by +$4.67 M (+14.09%)